logo

Sorrento Therapeutics, Inc. (SRNE)



Trade SRNE now with
  Date
  Headline
8/13/2018 4:01:56 AM Sorrento Therapeutics Says Sorrento Resiniferatoxin Phase 1B Trial Meets Both Safety And Efficacy Expectations
7/3/2018 9:31:58 AM Sorrento Therapeutics Acquires Sofusa Lymphatic Delivery Platform For Immune-Oncology Antibody Therapeutics
3/28/2018 9:34:11 PM Sorrento Therapeutics CEO Says Confident Of Executing Strategic Plan
3/27/2018 8:06:08 AM Sorrento Therapeutics Announces Unsecured $120.5 Mln Convertible Note Financing
3/19/2018 8:14:21 AM Sorrento Therapeutics Appoints Jiong Shao As EVP And CFO
3/5/2018 9:22:13 AM New Drugs Approved In February
1/24/2018 8:16:28 AM Sorrento Therapeutics Announces Expansion Of Its GMP CAR-T Manufacturing Capacity
9/12/2017 6:03:28 AM FDA Acknowledges Receipt Of Sorrento Therapeutics NDA For ZTlido™; PDUFA Date Set For February 28, 2018
8/29/2017 6:04:02 AM Sorrento Therapeutics Submits NDA For ZTlido Next-Generation Lidocaine Patch